Stay updated on Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section updated to indicate that entries are automatically filled from PubMed, and the revision version changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding notice banner warning of potential delays has been removed from the page, while the study details themselves remain unchanged.SummaryDifference0.4%

- Check34 days agoChange DetectedThe changes are minor UI/text updates on the study details page that do not affect enrollment, eligibility criteria, primary or secondary outcomes, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a government operating-status notice and a version upgrade; removed the prior version tag.SummaryDifference3%

- Check70 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.SummaryDifference0.2%

Stay in the know with updates to Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.